These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25055361)

  • 21. [Vascular calcifications in chronic kidney disease].
    Marinelli A; Loi MR; Londrino F; Logias F; Fiorini F; Granata A
    G Ital Nefrol; 2012; 29 Suppl 57():S83-9. PubMed ID: 23229533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular Calcification: An Important Understanding in Nephrology.
    Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
    Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
    Staude H; Jeske S; Schmitz K; Warncke G; Fischer DC
    Kidney Blood Press Res; 2013; 37(1):68-83. PubMed ID: 23548827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease].
    Phan O; Burnier M
    Rev Med Suisse; 2013 Feb; 9(375):451-2, 454-5. PubMed ID: 23539811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?
    Liabeuf S; Okazaki H; Desjardins L; Fliser D; Goldsmith D; Covic A; Wiecek A; Ortiz A; Martinez-Castelao A; Lindholm B; Suleymanlar G; Mallamaci F; Zoccali C; London G; Massy ZA
    Nephrol Dial Transplant; 2014 Jul; 29(7):1275-84. PubMed ID: 24009287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperphosphatemia. The hidden killer in chronic kidney disease.
    Askar AM
    Saudi Med J; 2015 Jan; 36(1):13-9. PubMed ID: 25629999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of Vascular Calcification in Kidney Disease.
    Disthabanchong S; Srisuwarn P
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):417-426. PubMed ID: 31831120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular calcification: from pathophysiology to biomarkers.
    Evrard S; Delanaye P; Kamel S; Cristol JP; Cavalier E;
    Clin Chim Acta; 2015 Jan; 438():401-14. PubMed ID: 25236333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison Of Vascular Calcification And Mineral Bone Disease In Non-Dialysis (CKD4/5ND) Vs Dialysis Dependent (CKD5D) Patients.
    ; Azam MN; Raja KM; Mir AW; Tahir T; Khan FR; Arshad AR; Butt B; ;
    J Ayub Med Coll Abbottabad; 2022; 34(1):118-121. PubMed ID: 35466639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of the mechanisms in vascular calcification during chronic kidney disease.
    Voelkl J; Cejka D; Alesutan I
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):289-296. PubMed ID: 30985336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate].
    Pavlović D; Katicić D; Josipović J
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The bone-vasculature-axis interaction: new insights into the pathogenesis of vascular calcification.].
    Cozzolino M; Galassi A; Bellasi A; Gallieni M; Brancaccio D
    G Ital Nefrol; 2007; 24(5):409-14. PubMed ID: 17886210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder.
    Tanaka H; Komaba H; Koizumi M; Kakuta T; Fukagawa M
    J Ren Nutr; 2012 Jan; 22(1):98-101. PubMed ID: 22200424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease.
    Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P
    Adv Clin Chem; 2008; 46():217-62. PubMed ID: 19004191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of pyrophosphate in vascular calcification in chronic kidney disease.
    Azpiazu D; Gonzalo S; González-Parra E; Egido J; Villa-Bellosta R
    Nefrologia (Engl Ed); 2018; 38(3):250-257. PubMed ID: 29137892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendations for mineral and bone disorder in chronic kidney disease].
    Staszków M; Przedlacki J
    Wiad Lek; 2014; 67(3):422-5. PubMed ID: 25782204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging for Vascular Calcification.
    Raggi P; O'Neill WC
    Semin Dial; 2017 Jul; 30(4):347-352. PubMed ID: 28332217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease.
    Shigematsu T; Sonou T; Ohya M; Yokoyama K; Yoshida H; Yokoo T; Okuda K; Masumoto AR; Iwashita Y; Iseki K; Kunimoto S; Yamano Y
    Contrib Nephrol; 2017; 189():169-177. PubMed ID: 27951564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.